Guideline-directed Weight Loss: 4 Questions for Primary Care Physicians

Article

Rapidly rising obesity rates in the US threaten to reverse decades of effort against cardiometabolic disease. How well do you know what experts recommend for your at-risk patients?

Recent Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
FDA Approves First Generic of Liraglutide Injection to Improve Glycemic Control in Patients with Type 2 Diabetes / Image credit: ©Argus/AdobeStock

FDA Approves First Generic of Liraglutide Injection to Improve Glycemic Control in Patients with Type 2 Diabetes

Sydney Jennings
December 23rd 2024
Article

The FDA has approved the first generic once-daily GLP-1 injection for the improvement of glycemic control for type 2 diabetes in patients 10 years and up.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Sydney Jennings
August 30th 2023
Podcast

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Smartphone App Shows Promise for Managing Hypertension in Observational Study / Image credit: ©ra2 studio/AdobeStock

Smartphone App Shows Promise for Managing Hypertension in Observational Study

Sydney Jennings
December 20th 2024
Article

People with hypertension who adhered to the mobile app demonstrated well-controlled blood pressure over a 12-week observational period.

Obesity & Type 2 Diabetes: An Expert Discussion

Obesity & Type 2 Diabetes: An Expert Discussion

Sydney Jennings
June 30th 2023
Podcast

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

Investigational Maridebart Cafraglutide Shows Promise for Obesity, T2D: Daily Dose / image credit: ©New Africa/AdobeStock

Investigational Maridebart Cafraglutide Shows Promise for Obesity, T2D: Daily Dose

Sydney Jennings
December 17th 2024
Article

Your daily dose of the clinical news you may have missed.

Tirzepatide Superior to Semaglutide in Weight Loss Trial: Daily Dose / image credit: ©New Africa/AdobeStock

Tirzepatide Superior to Semaglutide in Weight Loss Trial: Daily Dose

Sydney Jennings
December 16th 2024
Article

Your daily dose of the clinical news you may have missed.

© 2024 MJH Life Sciences

All rights reserved.